The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Locus coeruleus neurons contain norepinephrine-derived neuromelanin (227, 228); the dorsal motor nucleus of vagus contains neuromelanin that may be dopaminergic (202); and the raphe nuclei contain neuromelanin derived from their neurotransmitter, serotonin.”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [228]
In the citing paper
“In healthy ageing, selective accumulation of iron occurs in several brain regions and cell types, with iron mainly bound within ferritin and neuromelanin (panel).5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Neuromelanin is present in neurons as neuromelanin-iron complexes in which the iron content varies depending on the neurons in each brain area.6,53”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“Regional distribution of total iron in a healthy adult brain is heterogeneous; the highest iron concentrations were detected in the basal ganglia (putamen, globus pallidus, and caudate nucleus), whereas low concentrations were detected in the cortical grey matter, white matter, midbrain, and cerebellum, and the lowest iron concentrations were in the pons, locus coeruleus, and medulla.6,43,45–47”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [6]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease
Paulus, W., & Jellinger, K. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00006 · Cited by 554
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
Connor, J. R., Boyer, P. J., Menzies, S. L., Dellinger, B., Allen, R. P., Ondo, W. G., & Earley, C. J. (2003) · Neurology · doi:10.1212/01.wnl.0000078887.16593.12 · Cited by 548
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Research works printed but not linked: 5
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324.
- 10.1002/1531-8249(199910)46:4<598::aid-ana7>3.0.co;2-f · DOI
- Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L. & Lucius, R. (2003) FASEB J. 17, 500-502.12631585
- Blain, I., Slama, P., Giorgi, M., Tron, T. & Reglier, M. (2002) J. Biotechnol. 90, 95-112.12069196
- Marttila, R. J., Viljanen, M., Toivonen, E., Lorentz, H. & Rinne, U. K. (1990) Adv. Neurol. 53, 141-144.2239455
Cited by
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
Que, E. L., Domaille, D. W., & Chang, C. J. (2008) · Chemical Reviews · doi:10.1021/cr078203u · Cited by 2,061
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Self-citationIron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Self-citationInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
“In the pigment isolated from SN of healthy subjects, the concentration of iron is about 10 mg/mg of NM pigment (Zecca et al., 2004b, 2008b; Zucca et al., 2006), although NM can bind even higher quantities of iron (Shima et al., 1997; Zecca et al., 1996, 2004b).”
InfluentialSelf-citationIron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Solano, F. (2014) · New Journal of Science · doi:10.1155/2014/498276 · Cited by 565
Intracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526
“Oligodendrocytes have equal amounts of both H and L subunits, whereas microglia express L-rich ferritin, and neurons have H-subunit abundant ferritin (206, 333).”
Melanins and melanogenesis: from pigment cells to human health and technological applications
d'Ischia, M., Wakamatsu, K., Cicoira, F., Di Mauro, E., Garcia‐Borron, J. C., Commo, S., Galván, I., Ghanem, G., Kenzo, K., Meredith, P., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12393 · Cited by 490
Self-citationMelanins and melanogenesis: Methods, standards, protocols
d'Ischia, M., Wakamatsu, K., Napolitano, A., Briganti, S., Garcia‐Borron, J., Kovacs, D., Meredith, P., Pezzella, A., Picardo, M., Sarna, T., et al. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12121 · Cited by 484
A delicate balance: Iron metabolism and diseases of the brain
Hare, D., Ayton, S., Bush, A., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 443
Glutathione metabolism and Parkinson's disease
Smeyne, M., & Smeyne, R. J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.001 · Cited by 435
Pang, S. Y.-Y., Ho, P. W.-L., Liu, H.-F., Leung, C.-T., Li, L., Chang, E. E. S., Ramsden, D. B., & Ho, S.-L. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0165-9 · Cited by 427
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Giguère, N., Burke Nanni, S., & Trudeau, L.-E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00455 · Cited by 413
The Role of Selenium in Pathologies: An Updated Review
Barchielli, G., Capperucci, A., & Tanini, D. (2022) · Antioxidants · doi:10.3390/antiox11020251 · Cited by 371
Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1010 · Cited by 369
“Within the SN, NM is detected after the first year of life and its concentration increases with age [116].”
BackgroundLocus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-Cabronero, J., Callaghan, M. F., Lambert, C., Cardenas-Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 365
Self-citationAldazine-based colorimetric sensors for Cu2+ and Fe3+
Narayanaswamy, N., & Govindaraju, T. (2012) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2011.10.036 · Cited by 347
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338
Self-citationIn vivo mapping of the human locus coeruleus
Keren, N. I., Lozar, C. T., Harris, K. C., Morgan, P. S., & Eckert, M. A. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.012 · Cited by 308
Manganese and its Role in Parkinson’s Disease: From Transport to Neuropathology
Aschner, M., Erikson, K. M., Hernández, E. H., & Tjalkens, R. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8083-0 · Cited by 308
Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
Stankiewicz, J., Panter, S. S., Neema, M., Arora, A., Batt, C. E., & Bakshi, R. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.006 · Cited by 301
Iron in Neurodegeneration – Cause or Consequence?
Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 298
Selenium, selenoproteins and neurodegenerative diseases
Cardoso, B. R., Roberts, B. R., Bush, A. I., & Hare, D. J. (2015) · Metallomics · doi:10.1039/c5mt00075k · Cited by 295
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
Liu, J.-L., Fan, Y.-G., Yang, Z.-S., Wang, Z.-Y., & Guo, C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00632 · Cited by 284
Iron and dopamine: a toxic couple
Hare, D. J., & Double, K. L. (2016) · Brain · doi:10.1093/brain/aww022 · Cited by 283
Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition
Siddiq, A., Ayoub, I. A., Chavez, J. C., Aminova, L., Shah, S., LaManna, J. C., Patton, S. M., Connor, J. R., Cherny, R. A., Volitakis, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504963200 · Cited by 282
In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan
Acosta-Cabronero, J., Betts, M. J., Cardenas-Blanco, A., Yang, S., & Nestor, P. J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1907-15.2016 · Cited by 274
Monzani, E., Nicolis, S., Dell'Acqua, S., Capucciati, A., Bacchella, C., Zucca, F. A., Mosharov, E. V., Sulzer, D., Zecca, L., & Casella, L. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201811122 · Cited by 271
Self-citationSulzer, D., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0047-3 · Cited by 270
Self-citationZhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
“Isolation of NM from SN NM was prepared from human SN and characterized as reported (Zecca et al. 2004).”
Self-citationMetal based neurodegenerative diseases—From molecular mechanisms to therapeutic strategies
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2008) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.10.019 · Cited by 252
Brain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 248
Zinc and copper: Pharmacological probes and endogenous modulators of neuronal excitability
Mathie, A., Sutton, G. L., Clarke, C. E., & Veale, E. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.004 · Cited by 247
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Cassidy, C. M., Zucca, F. A., Girgis, R. R., Baker, S. C., Weinstein, J. J., Sharp, M. E., Bellei, C., Valmadre, A., Vanegas, N., Kegeles, L. S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807983116 · Cited by 244
Self-citationNeuromelanin of the Human Substantia Nigra: An Update
Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9435-y · Cited by 243
Self-citationZecca, L., Bellei, C., Costi, P., Albertini, A., Monzani, E., Casella, L., Gallorini, M., Bergamaschi, L., Moscatelli, A., Turro, N. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808768105 · Cited by 240
“For the sake of simplicity and classification, in the ensuing discussion all of these pigments from the different brain regions studied will be termed ‘‘neuromelanins,’’ to embrace a family of pigments, including both those described here and those we characterized in substantia nigra and locus coeruleus (2, 15).”
BackgroundInfluentialSelf-citationBrain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236
Zecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Zadlo, A., Szewczyk, G., Zareba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233
Self-citationClewett, D. V., Lee, T.-H., Greening, S., Ponzio, A., Margalit, E., & Mather, M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.019 · Cited by 226
Role of Iron in Neurodegenerative Disorders
Berg, D., & Youdim, M. B. H. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245461.90406.ad · Cited by 226
Histologic validation of locus coeruleus MRI contrast in post-mortem tissue
Keren, N. I., Taheri, S., Vazey, E. M., Morgan, P. S., Granholm, A.-C. E., Aston-Jones, G. S., & Eckert, M. A. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.03.020 · Cited by 225
Rostral locus coeruleus integrity is associated with better memory performance in older adults
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N. C., Lindenberger, U., Kühn, S., & Werkle-Bergner, M. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0715-2 · Cited by 223
Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation
Liu, B., Moloney, A., Meehan, S., Morris, K., Thomas, S. E., Serpell, L. C., Hider, R., Marciniak, S. J., Lomas, D. A., & Crowther, D. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158980 · Cited by 216
The role of free radicals in the aging brain and Parkinson’s Disease: Convergence and parallelism
Kumar, H., Lim, H.-W., More, S. V., Kim, B.-W., Koppula, S., Kim, I. S., & Choi, D.-K. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810478 · Cited by 212
Iron, myelin, and the brain: neuroimaging meets neurobiology
Möller, H. E., Bossoni, L., Connor, J. R., Crichton, R. R., Does, M. D., Ward, R. J., Zecca, L., Zucca, F. A., & Ronen, I. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.009 · Cited by 207
Self-citationZecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205
Self-citationOxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease
Gaki, G. S., & Papavassiliou, A. G. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8294-x · Cited by 200
MRI of healthy brain aging: A review
MacDonald, M. E., & Pike, G. B. (2021) · NMR in Biomedicine · doi:10.1002/nbm.4564 · Cited by 192
Lipopolysaccharide Animal Models for Parkinson's Disease
Liu, M., & Bing, G. (2011) · Parkinson's Disease · doi:10.4061/2011/327089 · Cited by 190
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Weinreb, O., Mandel, S., Youdim, M. B. H., & Amit, T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.017 · Cited by 190
Iron metabolism in Parkinsonian syndromes
Berg, D., & Hochstrasser, H. (2006) · Movement Disorders · doi:10.1002/mds.21020 · Cited by 186
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Isaias, I. U., Trujillo, P., Summers, P., Marotta, G., Mainardi, L., Pezzoli, G., Zecca, L., & Costa, A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00196 · Cited by 183
Self-citationHypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases
Merelli, A., Repetto, M., Lazarowski, A., & Auzmendi, J. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201074 · Cited by 181
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
Biondetti, E., Santin, M. D., Valabrègue, R., Mangone, G., Gaurav, R., Pyatigorskaya, N., Hutchison, M., Yahia-Cherif, L., Villain, N., Habert, M.-O., et al. (2021) · Brain · doi:10.1093/brain/awab191 · Cited by 181
Brain Iron Metabolism Dysfunction in Parkinson’s Disease
Jiang, H., Wang, J., Rogers, J., & Xie, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9879-1 · Cited by 180
Bao, W., Zhou, X., Zhou, L., Wang, F., Yin, X., Lu, Y., Zhu, L., & Liu, D. (2020) · Aging Cell · doi:10.1111/acel.13235 · Cited by 172
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171
“Moreover, neuromelanin is also released into extracellular space; such extracellular neuromelanin contains significant levels of iron, with higher levels of redox active iron in PD subjects [14, 31].”
BackgroundMitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders
Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 153
Noradrenergic modulation of rhythmic neural activity shapes selective attention
Dahl, M. J., Mather, M., & Werkle‐Bergner, M. (2021) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2021.10.009 · Cited by 172
Copper regulates rest-activity cycles through the locus coeruleus-norepinephrine system
Xiao, T., Ackerman, C. M., Carroll, E. C., Jia, S., Hoagland, A., Chan, J., Thai, B., Liu, C. S., Isacoff, E. Y., & Chang, C. J. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0062-z · Cited by 167
Hämmerer, D., Callaghan, M. F., Hopkins, A., Kosciessa, J., Betts, M., Cardenas-Blanco, A., Kanowski, M., Weiskopf, N., Dayan, P., Dolan, R. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712268115 · Cited by 167
Zucca, F. A., Vanna, R., Cupaioli, F. A., Bellei, C., De Palma, A., Di Silvestre, D., Mauri, P., Grassi, S., Prinetti, A., Casella, L., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0050-8 · Cited by 151
Self-citationIto, S., Sugumaran, M., & Wakamatsu, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176080 · Cited by 166
Iron overload: Effects on cellular biochemistry
Sousa, L., Oliveira, M. M., Pessôa, M. T. C., & Barbosa, L. A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.029 · Cited by 138
Contrast mechanisms associated with neuromelanin‐MRI
Trujillo, P., Summers, P. E., Ferrari, E., Zucca, F. A., Sturini, M., Mainardi, L. T., Cerutti, S., Smith, A. K., Smith, S. A., Zecca, L., et al. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26584 · Cited by 150
Self-citationHigh-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3T and 7T
Priovoulos, N., Jacobs, H. I. L., Ivanov, D., Uludağ, K., Verhey, F. R. J., & Poser, B. A. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2017.07.045 · Cited by 160
Cerebral Iron Deposition in Neurodegeneration
Dusek, P., Hofer, T., Alexander, J., Roos, P. M., & Aaseth, J. O. (2022) · Biomolecules · doi:10.3390/biom12050714 · Cited by 159
Bush, W. D., Garguilo, J., Zucca, F. A., Albertini, A., Zecca, L., Edwards, G. S., Nemanich, R. J., & Simon, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604010103 · Cited by 159
Self-citationCuriosity in old age: A possible key to achieving adaptive aging
Sakaki, M., Yagi, A., & Murayama, K. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.03.007 · Cited by 159
Ashraf, A., Clark, M., & So, P.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Ma, L., Gholam Azad, M., Dharmasivam, M., Richardson, V., Quinn, R. J., Feng, Y., Pountney, D. L., Tonissen, K. F., Mellick, G. D., Yanatori, I., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101896 · Cited by 148
Charkoudian, L. K., & Franz, K. J. (2006) · Inorganic Chemistry · doi:10.1021/ic060014r · Cited by 147
Iron, the substantia nigra and related neurological disorders
Snyder, A. M., & Connor, J. R. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.005 · Cited by 150
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects
Zucca, F. A., Giaveri, G., Gallorini, M., Albertini, A., Toscani, M., Pezzoli, G., Lucius, R., Wilms, H., Sulzer, D., Ito, S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00201.x · Cited by 134
Self-citationSpatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Biondetti, E., Gaurav, R., Yahia‐Cherif, L., Mangone, G., Pyatigorskaya, N., Valabrègue, R., Ewenczyk, C., Hutchison, M., François, C., Arnulf, I., et al. (2020) · Brain · doi:10.1093/brain/awaa216 · Cited by 149
Age and sex related differences in subcortical brain iron concentrations among healthy adults
Persson, N., Wu, J., Zhang, Q., Liu, T., Shen, J., Bao, R., Ni, M.-F., Liu, T., Wang, Y., & Spincemaille, P. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.07.050 · Cited by 147
Ferritin as an important player in neurodegeneration
Friedman, A., Arosio, P., Finazzi, D., Koziorowski, D., & Gałązka-Friedman, J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.03.016 · Cited by 143
Self-citationMapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence
Popescu, B. F. G., George, M. J., Bergmann, U., Garachtchenko, A., Kelly, M., McCrea, R. P. E., Luening, K., Devon, R. M., George, G. N., Hanson, A. D., et al. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/3/012 · Cited by 141
Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 127
Zucca, F. A., Bellei, C., Giannelli, S. G., Terreni, M., Gallorini, M., Rizzio, E., Pezzoli, G., Albertini, A., & Zecca, L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0453-2 · Cited by 138
Self-citationA proposed dual role of neuromelanin in the pathogenesis of Parkinson’s disease
Zecca, L., Zucca, F. A., Albertini, A., Rizzio, E., & Fariello, R. G. (2006) · Neurology · doi:10.1212/wnl.67.7_suppl_2.s8 · Cited by 118
Self-citationHegde, M. L., Shanmugavelu, P., Vengamma, B., Rao, T. S., Menon, R. B., Rao, R. V., & Rao, K. S. J. (2004) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2004.09.003 · Cited by 136
The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
Beardmore, R., Hou, R. H., Darekar, A., Holmes, C., & Boche, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210191 · Cited by 135
Insights into Melanosomes and Melanin from Some Interesting Spatial and Temporal Properties
Simon, J. D., Hong, L., & Peles, D. N. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp804248h · Cited by 118
Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System
Kim, B.-W., Jeong, K. H., Kim, J.-H., Jin, M., Kim, J.-H., Lee, M.-G., Choi, D.-K., Won, S.-Y., McLean, C., Jeon, M.-T., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.4261-15.2016 · Cited by 117
Iron homeostasis imbalance and ferroptosis in brain diseases
Long, H., Zhu, W., Wei, L., & Zhao, J. (2023) · MedComm · doi:10.1002/mco2.298 · Cited by 128
α-Synuclein in Parkinson’s disease: causal or bystander?
Riederer, P. F., Berg, D., Casadei, N., Cheng, F., Claßen, J., Dresel, C., Jost, W. H., Krüger, R., Müller, T., Reichmann, H., et al. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02025-9 · Cited by 128
Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions
Tarnacka, B., Jopowicz, A., & Maślińska, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157820 · Cited by 127
Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis
You, L.-H., Yan, C.-Z., Zheng, B.-J., Ci, Y.-Z., Chang, S.-Y., Yu, P., Gao, G.-F., Li, H.-Y., Dong, T.-Y., & Chang, Y.-Z. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.93 · Cited by 118
Locus coeruleus-norepinephrine: basic functions and insights into Parkinson’s disease
Bari, B. A., Chokshi, V. B., & Schmidt, K. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.270297 · Cited by 126
Iron and reactive oxygen species activity in parkinsonian substantia nigra
del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 126
Hare, D. J., Lei, P., Ayton, S., Roberts, B. R., Grimm, R., George, J. L., Bishop, D., Beavis, A. D., Donovan, S. J., McColl, G., et al. (2014) · Chemical Science · doi:10.1039/c3sc53461h · Cited by 125
Copper and the brain noradrenergic system
Lutsenko, S., Washington-Hughes, C., Ralle, M., & Schmidt, K. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01737-3 · Cited by 119
Cheng, Z., He, N., Huang, P., Li, Y., Tang, R., Sethi, S. K., Ghassaban, K., Yerramsetty, K. K., Palutla, V. K., Chen, S., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102103 · Cited by 119
Bohic, S., Murphy, K., Paulus, W., Cloetens, P., Salomé, M., Susini, J., & Double, K. (2008) · Analytical Chemistry · doi:10.1021/ac801817k · Cited by 109
Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases
Doroszkiewicz, J., Farhan, J. A., Mroczko, J., Winkel, I., Perkowski, M., & Mroczko, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115721 · Cited by 115
Copper- and iron-induced differential fibril formation in α-synuclein: TEM study
..., B., Indi, S. S., & Rao, K. S. J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.052 · Cited by 115
Pathogenesis of Wilson disease
Scheiber, I. F., Brůha, R., & Dušek, P. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63625-6.00005-7 · Cited by 113
Schmidt, K., Ralle, M., Schaffer, T., Jayakanthan, S., Bari, B. A., Muchenditsi, A., & Lutsenko, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004889 · Cited by 113
Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease
Isaya, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00029 · Cited by 109
Metadata
- Authors
- Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., Karatekin, E., Kleinman, M. H., Turro, N., Hornykiewicz, O., & Zucca, F. A.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Vienna (AT)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-21
- Volume
- 101
- Issue
- 26
- Pages
- 9843-9848
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC470762
- OpenAlex
- W2116294955
- Cited by
- 495
- References
- 51
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 31 · 2023: 30 · 2022: 37 · 2021: 46 · 2020: 31 · 2019: 41 · 2018: 23 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 18 · 2013: 14 · 2012: 21
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron, copper, locus coeruleus, substantia nigra, Parkinson's disease, neuronal vulnerability, aging, neuromelanin, ferritin, ceruloplasmin, manganese superoxide dismutase, copper-zinc superoxide dismutase, iron mobilization, iron toxicity, brainstem
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Ceruloplasmin, Copper, Electron Spin Resonance Spectroscopy, Female, Ferritins, Homeostasis, Humans, Iron, Iron Chelating Agents, Locus Coeruleus, Male, Melanins, Middle Aged, Neuroglia, Neurons, Substantia Nigra, Superoxide Dismutase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.